{"name":"Onconova Therapeutics","permalink":"onconova-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/onconova-therapeutics","homepage_url":"http://www.onconova.com","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"","phone_number":"267-759-3680","description":"A private biopharmaceutical company ","created_at":"Wed Aug 15 05:20:39 UTC 2012","updated_at":"Fri Sep 21 02:47:25 UTC 2012","overview":"<p>Onconova Therapeutics is a private biopharmaceutical company providing innovative solutions for treating cancer and combating radiation injury. The company currently has one Phase III clinical-stage compound, two Phase I products in clinical development, and more than a half-dozen, well-differentiated preclinical compounds. The most advanced product, rigosertib (EstybonÂ®, ON 01910.Na), is now in a pivotal trial being conducted under a Special Protocol Assessment (SPA) from the United States FDA for myelodysplastic syndrome (MDS), as well as in a Phase II trial for ovarian cancer and a Phase II/III trial for pancreatic cancer.</p>","image":{"available_sizes":[[[150,41],"assets/images/resized/0020/6140/206140v1-max-150x150.jpg"],[[231,64],"assets/images/resized/0020/6140/206140v1-max-250x250.jpg"],[[231,64],"assets/images/resized/0020/6140/206140v1-max-450x450.jpg"]],"attribution":null},"products":[],"relationships":[],"competitions":[],"providerships":[],"total_money_raised":"$50M","funding_rounds":[{"round_code":"unattributed","source_url":"http://www.fiercebiotech.com/story/onconova-hauls-50m-fuel-late-stage-leukemia-program/2012-08-14?utm_source=rss&utm_medium=rss","source_description":"Onconova hauls in $50M to fuel late-stage leukemia program","raised_amount":50000000,"raised_currency_code":"USD","funded_year":2012,"funded_month":8,"funded_day":14,"investments":[]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"375 Pheasant Run","address2":"","zip_code":"18940","city":"Newtown","state_code":"PA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[{"description":" Onconova Lands $565M Deal with Baxter, Looks Ahead to Possible Regulatory Filing ","stoned_year":2012,"stoned_month":9,"stoned_day":20,"source_url":"http://pevc.dowjones.com/article?an=DJFVW00020120920e89ktstno&from=alert&pid=32&ReturnUrl=http%3a%2f%2fpevc.dowjones.com%3a80%2farticle%3fan%3dDJFVW00020120920e89ktstno%26from%3dalert%26pid%3d32","source_text":"","source_description":" Onconova Lands $565M Deal with Baxter, Looks Ahead to Possible Regulatory Filing ","stoneable_type":"Company","stoned_value":null,"stoned_value_type":null,"stoned_acquirer":null,"stoneable":{"name":"Onconova Therapeutics","permalink":"onconova-therapeutics"}}],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,128],"assets/images/resized/0020/6141/206141v1-max-150x150.jpg"],[[250,214],"assets/images/resized/0020/6141/206141v1-max-250x250.jpg"],[[450,385],"assets/images/resized/0020/6141/206141v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}